The case for initial treatment with intrauterine insemination as opposed to in vitro fertilization for idiopathic infertility

Human Fertility

Volumn 6, Issue 3, 2003, Pages 122-124

  Homburg, Roy ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH RATE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; GYNECOLOGY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; IDIOPATHIC DISEASE; INFERTILITY; INTRAUTERINE INSEMINATION; MEDICAL SPECIALIST; MULTIPLE PREGNANCY; OBSTETRICS; OVARY FUNCTION; PATIENT COMPLIANCE; PREGNANCY COMPLICATION; PREGNANCY RATE; STIMULATION; VALIDATION PROCESS;

COST-BENEFIT ANALYSIS; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; INSEMINATION, ARTIFICIAL, HOMOLOGOUS; PREGNANCY; PREGNANCY RATE; PREGNANCY, MULTIPLE; RANDOMIZED CONTROLLED TRIALS;

EID: 2342647398     PISSN: 14647273     EISSN: None     Source Type: Journal    
DOI: 10.1080/1464770312331369373     Document Type: Article

References (16)

1. Collins J (2003) Current best evidence for the advanced treatment of unexplained infertility Human Reproduction 18 907-912
2. Crosignani PG, Walters DE and Soliani A (1991) The ESHRE multicentre trial on the treatment of unexplained infertility: a preliminary report Human Reproduction 6 953-958
3. Gleicher N and Karande V (2001) Forget about ovulation induction! Proceed directly to IVF. In proceedings of the 2nd World Congress on Controversies in Obstetrics and Gynecology pp 211-215 Eds Z Ben-Raphael, Z Shoham and R Frydman. Monduzzi Editore, Bologna
4. Goverde AJ, McDonnell J, Vermeiden JW, Schats R, Rutten FH and Schoemaker J (2000) Intrauterine insemination or in vitro fertilization in idiopathic subfertility and male subfertility: a randomized trial and cost effectiveness analysis Lancet 355 13-18
5. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP and Steikampf MP (1998) Efficacy of treatment for unexplained infertility Fertility and Sterility 70 207-213
6. Homburg R and Insler V (2002) Ovulation induction in perspective Human Reproduction Update 8 449-462
7. Hughes EG (2003) 'Effective treatment' or 'not a natural choice'? Human Reproduction 18 912-914
8. Human Fertilisation and Embryology Authority (2002) Annual Report HFEA, London
9. Karande VC, Korn A, Morris R, Rao R, Balin M, Rinehart J, Dohn I and Gleicher N (1999) Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of traditional treatment algorithm as first line therapy for couples with infertility Fertility and Sterility 71 468-475
10. Khalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S and Westergaard LG (2001) Homologous intrauterine insemination. An evaluation of prognostic factors based on a review of 2473 cycles Acta Obstetricia et Gynecologica Scandinavica 80 74-81
11. Nygren KG and Andersen AN (2002) Assisted reproductive technology in Europe, 1999. Results generated from European registers by ESHRE Human Reproduction 17 3260-3274
12. Pandian Z, Bhattacharya S, Nikolaou D, Vale L and Templeton A (2002) In vitro fertilization for unexplained subfertility Cochrane Database of Systematic Reviews 2 CD003357
13. Peterson CM, Hatasaka HH, Jones KP, Poulson AM, Jr, Carrell DT and Urry RL (1994) Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: a prospective, non-randomized, cohort study and meta-analysis Fertility and Sterility 62 535-544
14. Royal College of Obstetricians and Gynaecologists (1998) The Management of Infertility in Secondary Care - Evidence Based Guidelines No. 3 RCOG Press, London
15. Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine (2002) Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine-Society for Assisted Reproductive Technology Registry Fertility and Sterility 78 918-928
16. Stewart JA (2003) Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. Should the guidelines be changed? Human Reproduction 18 903-907